Comparing the effect of 2 different physical therapies in managing jaw joint diseases

Effectiveness of therapeutic ultrasound versus transcutaneous electric nerve stimulation as a pain controlling modality in temporomandibular joint disorders : a randomized control trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/047713

Enrollment

Registered

2022-11-28

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures Health Condition 2: M255- Pain in joint

Interventions

Intervention1: ULTRASOUND THERAPY: ULTRASOUND THERAPY USING THERAPEUTIC ULTRASOUND UNIT OF FREQUENCY 1MHZ IN CONTINUOUS MODE FOR FOUR SESSIONS(ONCE A WEEK FOR 4 WEEKS) WITH A DURATION OF 10 MINUTES Co

Eligibility

Inclusion criteria

Inclusion criteria: 1. TMD patients with clinical features of pain and masticatory muscle tenderness, pain while opening and closing mouth in the age group of 18-50 years. 2. Patients being treated with other drug therapy will be considered provided a washout period of at least 3 weeks will be allowed before inclusion in the study

Exclusion criteria

Exclusion criteria: 1. Patients with definite radiographic changes involving TMJ. 2. Patients with a history of maxillofacial trauma. 3. Patients with a history of polyarthritis, joint infection, surgical treatment, physiotherapy, splint therapy, or acupuncture within the 4 months before the study 4. Orofacial infections and developmental anomalies of the maxillofacial region. 5. Patients with cardiac pacemakers, history of seizures, depression, other mental and vascular disorders, bleeding disorders, respiratory disease, and other diseases that might impact the outcome assessments. 6. Pregnancy 7. Patients with brain tumors, neoplasia, or neurological disorders involving the head and neck like Bell’s palsy, multiple sclerosis, and Tourette syndrome. 8. Patients who have been treated with TENS or Ultrasound therapy previously without any improvement in the conditions. 9. Allergy to adhesive tapes or electrodes of TENS or Ultrasound gel.

Design outcomes

Primary

Measure	Time frame
PAIN IS MEASURED USING VISUAL ANALOGUE SCALE Timepoint: 1.BEFORE THE TREATMENT 2.AFTER THE TREATMENT	—

Secondary

Measure	Time frame
PRESSURE PAIN THRESHOLD IS MEASURED USING PRESSURE ALGOMETERTimepoint: 1. BEFORE THE TREATMENT 2. AFTER THE TREATMENT	—

Countries

India

Contacts

Public ContactDR LAKSHMI B

GOVERNMENT DENTAL COLLEGE, KOTTAYAM

drsreelajkumar@gmail.com9447009888

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026